Overview
Clarium is a healthcare supply-chain AI company whose platform, Astra OS, unifies hospital and supplier data to deliver end-to-end visibility and resilience. It monitors for disruptions in real time, predicts shortages, automates approval of clinically equivalent substitutes, and optimizes operating-room supplies and procedure cards. Customers include Yale New Haven Health, Stanford Medicine, Geisinger, Ochsner and Boston Children's Hospital.
Funding and Investors
Founded in 2020 by Steve Liou, Clarium has raised roughly $43 million, including a $27 million Series A in 2025 led by Northzone with participation from General Catalyst, AlleyCorp, Kaiser Permanente Ventures and Texas Medical Center Ventures. The company targets the persistent inefficiency and fragility of hospital supply chains.
Why It Matters
Hospital supply chains are notoriously fragmented and vulnerable to shortages that directly affect patient care. By giving health systems predictive visibility and automated substitution workflows, Clarium reduces disruptions, waste and manual effort across one of healthcare's costliest operational areas.
